Coiled Therapeutics PLC 0AG0
Trading Information
- Previous Close Price
- €0.06
- Day Range
- €0.06–0.06
- 52-Week Range
- €0.00–0.17
- Bid/Ask
- €0.06 / €0.10
- Shares Outstanding
- 426.79M
- Market Cap
- €24.80M
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Coiled Therapeutics PLC is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 0
- Website
- https://www.coiledplc.com
Valuation
|
Metric
|
0AG0
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.56 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
0AG0
|
|---|---|
Quick Ratio | 29.73 |
Current Ratio | 29.73 |
Interest Coverage | −424.19 |
Quick Ratio
0AG0
Profitability
|
Metric
|
0AG0
|
|---|---|
Return on Assets (Normalized) | −12.67% |
Return on Equity (Normalized) | −16.10% |
Return on Invested Capital (Normalized) | −12.78% |
Return on Assets
0AG0
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|%nT!M# | LOCK|<KR$ | $129B | |||
| Moderna Inc
MRNA
| LOCK|?$%&fY! | LOCK|J&X | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|HwFFP@t | LOCK|Bj$c | $79B | |||
| argenx SE ADR
ARGX
| LOCK|K#d$<> | LOCK|b!Q | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|tdsjQy$ | LOCK|lW% | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|k&z#$C | LOCK|@W<& | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|QgwPLlX | LOCK|%RlC | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|%?R!#jL | LOCK|r%n | $24B | |||
| Incyte Corp
INCY
| LOCK|^$&z%F& | LOCK|PMD | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|@$$MR&D | LOCK|WH> | $14B |
United States